Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer
开发一种基于个性化肿瘤新抗原的疫苗制剂（FRAME-001），用于治疗晚期非小细胞肺癌的II期临床试验
期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics14071515
Oosting, Linette T; Franke, Katka; Martin, Michael V; Kloosterman, Wigard P; Jamieson, Jennifer A; Glenn, Laura A; de Jager, Miranda W; van Zanten, Jacoba; Allersma, Derk P; Gareb, Bahez
